INmune Bio
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell INmune Bio and other ETFs, options, and stocks.About INMB
INmune Bio, Inc. is a clinical stage biotechnology company, which engages in developing new immunotherapies that reprogram the immune system to fight cancer and Alzheimer’s disease. Its product pipeline includes INKMUNE-Cancer, INB03-Cancer, XPRO1595-Alzheimer and TRD, and LIVNate.
INMB Key Statistics
Stock Snapshot
INmune Bio(INMB) stock is priced at $2.05, giving the company a market capitalization of 54.37M. It carries a P/E multiple of -1.00.
On 2025-12-12, INmune Bio(INMB) stock moved within a range of $2.02 to $2.19. With shares now at $2.05, the stock is trading +1.2% above its intraday low and -6.6% below the session's peak.
Trading volume for INmune Bio(INMB) stock has reached 408.07K, versus its average volume of 650.29K.
The stock's 52-week range extends from a low of $1.38 to a high of $11.64.
The stock's 52-week range extends from a low of $1.38 to a high of $11.64.
INMB News
Just because a business does not make any money, does not mean that the stock will go down. For example, although software-as-a-service business Salesforce.com...
TipRanks Cyber Monday Sale Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence. Subscribe to TipRank...